These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26825342)

  • 21. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
    J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.
    Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A
    Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint forces of mass spectrometric techniques (ICP-MS and MALDI-TOF-MS) and fluorescence spectrometry in the study of platinum-based cytostatic drugs interactions with metallothionein MT2 and MT3.
    Pavelicova K; Do T; Vejvodova M; Vaculovic T; Nowak K; Matczuk M; Wu S; Krężel A; Adam V; Vaculovicova M
    Talanta; 2024 Jul; 274():125920. PubMed ID: 38574532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual Internal Standards with Metals and Molecules for MALDI Imaging of Kidney Lipids.
    Aboulmagd S; Esteban-Fernández D; Moreno-Gordaliza E; Neumann B; El-Khatib AH; Lázaro A; Tejedor A; Gómez-Gómez MM; Linscheid MW
    Anal Chem; 2017 Dec; 89(23):12727-12734. PubMed ID: 29124930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of powder samples using screen-printing techniques as sample preparation methods for LA-ICP-MS.
    Kobayashi M; Namiki H; Hayashi H
    Anal Sci; 2023 Oct; 39(10):1757-1762. PubMed ID: 37528280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS): comparison of different internal standardization methods using laser-induced plasma (LIP) emission and LA-ICP-MS signals.
    Ohata M; Yasuda H; Namai Y; Furuta N
    Anal Sci; 2002 Oct; 18(10):1105-10. PubMed ID: 12400655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging of metals, metalloids, and non-metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) in biological tissues.
    Becker JS; Becker JS
    Methods Mol Biol; 2010; 656():51-82. PubMed ID: 20680584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of platinum-based drugs with native biologically relevant proteins.
    Brauckmann C; Wehe CA; Kieshauer M; Lanvers-Kaminsky C; Sperling M; Karst U
    Anal Bioanal Chem; 2013 Feb; 405(6):1855-64. PubMed ID: 23052861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomonitoring of essential and toxic metals in single hair using on-line solution-based calibration in laser ablation inductively coupled plasma mass spectrometry.
    Dressler VL; Pozebon D; Mesko MF; Matusch A; Kumtabtim U; Wu B; Sabine Becker J
    Talanta; 2010 Oct; 82(5):1770-7. PubMed ID: 20875575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.
    Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
    J Mass Spectrom; 2015 Jun; 50(6):844-53. PubMed ID: 26169139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor.
    Bianga J; Bouslimani A; Bec N; Quenet F; Mounicou S; Szpunar J; Bouyssiere B; Lobinski R; Larroque C
    Metallomics; 2014 Aug; 6(8):1382-6. PubMed ID: 24984817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin nephrotoxicity: in vitro studies with precision-cut rabbit renal cortical slices.
    Phelps JS; Gandolfi AJ; Brendel K; Dorr RT
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):501-12. PubMed ID: 3310337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) to characterize copper, zinc and mercury along grizzly bear hair providing estimate of diet.
    Noël M; Christensen JR; Spence J; Robbins CT
    Sci Total Environ; 2015 Oct; 529():1-9. PubMed ID: 26005744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in binding kinetics, bond strength and adduct formation between Pt-based drugs and S- or N-donor groups: A comparative study using mass spectrometry techniques.
    Artiaga G; Iglesias-Jiménez A; Moreno-Gordaliza E; Mena ML; Gómez-Gómez MM
    Eur J Pharm Sci; 2019 Apr; 132():96-105. PubMed ID: 30844436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative bioimaging of platinum in polymer embedded mouse organs using laser ablation ICP-MS.
    Reifschneider O; Wehe CA; Raj I; Ehmcke J; Ciarimboli G; Sperling M; Karst U
    Metallomics; 2013 Oct; 5(10):1440-7. PubMed ID: 23934158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of platinum agents, cisplatin, carboplatin and oxaliplatin against albumin in vivo rats and in vitro study using inductively coupled plasma-mass spectrometory.
    Kato R; Sato T; Iwamoto A; Yamazaki T; Nakashiro S; Yoshikai S; Fujimoto A; Imano H; Ijiri Y; Mino Y; Chikuma M; Tanaka K; Hayashi T
    Biopharm Drug Dispos; 2019 Jul; 40(7):242-249. PubMed ID: 31219617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung tumour growth delay and normal tissue toxicity induced by three cytotoxic platinum drugs.
    van Rongen E; Kal HB; Kuijpers WC; van Berkel AH
    Strahlenther Onkol; 1992 May; 168(5):300-7. PubMed ID: 1598667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model.
    Holmes J; Stanko J; Varchenko M; Ding H; Madden VJ; Bagnell CR; Wyrick SD; Chaney SG
    Toxicol Sci; 1998 Dec; 46(2):342-51. PubMed ID: 10048138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.